To confirm the above findings, we used the AXL-specific small molecule inhibitor TP-0903 to evaluate the cell cytotoxicity of AXL inhibition plus WIN55212-2 treatment in multiple cancer cell lines. This evidence concerns the gene AXL and cancer.